1-(2,3,4-Trimethoxybenzyl)piperazine
Aliases: 2,3,4-trimethoxybenzyl
Categories
Summary
WARNING: This substance has NO documented human usage data. There are no published studies, experience reports, or verified user accounts for this compound. ALL dosage, duration, and effects information is purely speculative extrapolation from structurally related benzylpiperazines (BZP, 2C-B-BZP) and should NOT be considered reliable or safe. This compound exists primarily as a laboratory research reagent. The pharmacology, metabolism, toxicity profile, and safe dose ranges are completely unknown.
Dose Information
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Peak | Offset | After Effects |
|---|---|---|---|---|
| Oral | 30-90 min | 2-4 hrs | 1-3 hrs | 2-6 hrs |
Tolerance
Build-up
develops over days to weeks of regular use
Reset
3–7 days for acute tolerance; longer for full reset
Effects
Positive
- Stimulation
Negative
- Pupil dilation
- Bruxism
- Nausea
- Tachycardia
- Insomnia
- Teeth grinding
- Vasoconstriction
- Headache
- Elevated blood pressure
Positive
- Euphoria
- Increased sociability
- Enhanced music appreciation
- Alertness enhancement
- Wakefulness
- Empathy Enhancement
- Focus enhancement
Negative
- Anxiety
- Dizziness
- Talkativeness
Positive
- Visual enhancement
- Pattern recognition enhancement
- Colour enhancement
- Tactile enhancement
- Bodily control enhancement
- Color Enhancement
- Tracers
Negative
- Appetite suppression
- Light sensitivity
- Closed-Eye Visuals